The three human ␤-defensins, HBD1-3, are 33-47-residue, cationic antimicrobial proteins expressed by epithelial cells. All three proteins have broad spectrum antimicrobial activity, with HBD3 consistently being the most potent. Additionally, HBD3 has significant bactericidal activity against Gram-positive Staphylococcus aureus at physiological salt concentrations. We have compared the multimeric state of the three ␤-defensins using NMR diffusion spectroscopy, dynamic and static light scattering, and analysis of the migration of the three ␤-defensins on a native gel. All three techniques are in agreement, suggesting that HBD-3 is a dimer, while HBD-1 and HBD-2 are monomeric. Subsequently, the NMR solution structures of HBD1 and HBD3 were determined using standard homonuclear techniques and compared with the previously determined solution structure of HBD2. Both HBD1 and HBD3 form well defined structures with backbone root mean square deviations of 0.451 and 0.616 Å, respectively. The tertiary structures of all three ␤-defensins are similar, with a short helical segment preceding a three-stranded antiparallel ␤-sheet. The surface charge density of each of the defensins is markedly different, with the surface of HBD3 significantly more basic. Analysis of the NMR data and structures led us to suggest that HBD3 forms a symmetrical dimer through strand ␤2 of the ␤-sheet. The increased anti-Staphylococcal activity of HBD3 may be explained by the capacity of the protein to form dimers in solution at low concentrations, an amphipathic dimer structure, and the increased positive surface charge compared with HBD1 and HBD2.
Antimicrobial peptides have been shown to be key elements in the innate immune system of many organisms, presenting the first line of defense against invading microbes. In many vertebrates the primary family of antimicrobial peptides are the defensins, produced in neutrophils and epithelial cells (1, 2) , although related proteins are also found in insects and plants (2, 3) . Defensins are small, 3-5 kDa cationic proteins constrained by three disulfide bonds. As a class of proteins, they have broad microbicidal activity against Gram-positive and -negative bacteria, yeast, and some enveloped viruses, although specific defensin peptides often have defined spectra of activity (2) . Like many other antimicrobial peptides (4), the defensin class of peptides is known to disrupt the membranes of microbes (5) (6) (7) . It has recently been reported that in addition to their antimicrobial activity, defensins may act as chemokines, activating the adaptive immune response (8 -10) .
The ␣-defensins were the first characterized human defensins (11) , including the human neutrophil proteins HNP1-3, which are stored in neutrophil granules and are released after phagocytosis of an invading bacterium. The isolation of the inducible tracheal antimicrobial protein from epithelial cells (12) and the subsequent discovery of 13 peptides stored in the granules of bovine neutrophils (13) represented a second class of defensins termed the ␤-defensins. These peptides differed from the ␣-defensins in the location of their six Cys residues and the specific pairing of their disulfide bridges. Since the initial report of the existence of ␤-defensins, their presence in the epithelial cells of many other organisms including humans, sheep, mice, rats, pigs, and chickens have been described (1) .
The first human ␤-defensin (HBD1), 1 initially isolated from hemofiltrates (14) , was subsequently found in human urine (15) and has been determined to be primarily expressed in the kidney and female urogenital tract (15) . In addition, it is abundantly expressed in breast milk (16, 17) . HBD1 was initially isolated as a mixture of forms of varying sizes (36 -47 amino acids) due to proteolytic cleavage. Of these different forms, the recombinant 36-residue HBD1 was found to be consistently the most potent, even at high salt concentrations. HBD1 is constitutively expressed, and its expression is neither up-regulated by the presence of bacteria nor in response to an inflammatory stimulus (2, 18) .
A second ␤-defensin was isolated from the skin of patients with psoriasis, and its sites of expression were determined to include the epithelial cells of the trachea, skin, and lung tissues (19) . HBD2 is active against many Gram-negative bacteria, including Escherichia coli and Pseudomonas aeruginosa as well as the yeast Candida albicans but was only found to be bacteriostatic, not bactericidal, against the Gram-positive bacteria, Staphylococcus aureus. In contrast to HBD1, HBD2 is inducible after bacterial challenge, with the level of mRNA increasing in the presence of Gram-negative and -positive bacteria, yeast, and proinflammatory cytokines, including tumor necrosis factor ␣ and interleukin-1␤ (2, 19 -21) .
As previously mentioned, both HBD1 and HBD2 have either little or no activity against S. aureus, which recently prompted Harder et al. (7) to search for a ␤-defensin with increased potency against S. aureus. A third human ␤-defensin, HBD3, was subsequently isolated from the epidermal keratinocytes of patients with psoriasis. Concurrently, the gene encoding HBD3 was independently described by two groups (22, 23) based on the observation that both the ␣ and ␤ defensins exist as a gene cluster on chromosome 8p23-p22. HBD3 is much more basic compared with the two other human ␤-defensins, having a total of 13 Arg and Lys residues compared with 6 and 7 cationic residues for HBD1 and HBD2, respectively. HBD3 possesses bactericidal activity against Gram-positive and -negative bacteria, including multi-drug-resistant S. aureus, vancomycinresistant Enterococcus faecium, and Burkholderia cepacia in addition to the yeast C. albicans (7, 23) .
2 HBD3 was demonstrated to retain its microbicidal activity against S. aureus at physiological salt concentrations although demonstrating little hemolytic activity in the presence of phosphate-buffered saline. A synthetic HBD3 peptide has recently been reported to form non-selective ion channels in the membranes of Xenopus laevis oocytes (23) . Like HBD2, HBD3 expression is inducible by external stimuli, including interleukin-1␤, tumor necrosis factor-␣, interferon-␥, and Gram-negative and -positive bacteria (7, 22, 23) . Expression of HBD3 is localized to heart, skeletal muscle, placenta, esophagus, trachea, oral mucosa, and skin tissues (22, 23) .
The three-dimensional structures of a number of defensins have been determined by both NMR and x-ray crystallography techniques (reviewed in Ref. 6 ). The first ␤-defensin structure to be determined was for bovine neutrophil ␤-defensin 12 (24) . Recently, the first structures of a human ␤-defensin were reported for HBD2 by NMR (25) and x-ray crystallography techniques (26) . In addition, the x-ray crystal structure of HBD1 has recently been described (27) . The structures of a number of proteins found in scorpion and marsupial venoms appear to have structural folds similar to the defensin family (28, 29) . The ability of ␤-defensins to act in a similar manner to chemokines has been exemplified by the structural similarities observed for ␤-defensins and chemokines, as recently reported for the NMR structure of MIP-3␣ (30) .
We describe here the NMR solution structures of two human ␤-defensins, HBD1 and HBD3. Additionally, various techniques, including light scattering, NMR diffusion, and native gel electrophoresis, were utilized to determine the multimeric states of HBD1-3 at various concentrations. The two human ␤-defensin solution structures have been compared with the previously determined solution structure of HBD2. The NMR structures, in combination with the information on the multimeric states of the three defensins, have been interpreted in an attempt to explain the biological differences observed among these three related antimicrobial proteins.
EXPERIMENTAL PROCEDURES
Materials-HBD1 (36 residues), HBD2 (41 residues), and HBD3 (45 residues) were recombinantly produced in E. coli using a proprietary fusion protein expression system by Peprotech (Rocky Hill, NJ). After purification, the peptides were refolded, and the disulfide bonds were oxidized. The purity of the peptides was verified by mass spectroscopy and capillary electrophoresis, demonstrating homogenous preparations for each of the peptides. Only single bands representing the monomeric form of each of the ␤-defensins were detected of the appropriate mass and charge. In addition, high performance liquid chromatography of HBD3 demonstrated an identical elution profile as the native peptide. 3 Our NMR results (see "Spectral Acquisition/Assignment" in the "Results" section) confirmed the homogeneity of the preparation. The antimicrobial properties of the recombinant peptides were confirmed by a radial diffusion assay. 2 Additionally, the activity of the recombinant HBD3 has been independently compared with the native peptide, with no significant differences observed.
3 Perdeuterated D 2 O was purchased from Cambridge Isotope laboratories, Inc. (Andover, MA).
PAGE Methods-Electrophoresis of 1 g of HBD1, HBD2, and HBD3 was performed under reduced and non-reduced conditions. Each sample contained 1 g of peptide and 10 l of 2ϫ sample buffer (Novex Tricine SDS sample buffer LC1676). In addition, the reduced samples contained 2 l of 500 mM dithiothreitol (50 mM final concentration). All samples were diluted with 0.02% acetic acid to a total volume of 20 l and heated to 100°C for 5 min. The entire sample was loaded and run on a 16% Tricine gel (Invitrogen, EC66952). The gel was then stained with Coomassie dye.
Light-scattering Experiments-For light-scattering studies, solutions of various protein concentrations were prepared in 0.1 M Tris, pH 8.0, buffer. The previously determined extinction coefficient for HBD2 (25) of 0.43 ml mg Ϫ1 cm Ϫ1 was used for purposes of determining HBD2 concentrations. Furthermore, in this study an extinction coefficient of 0.64 ml mg Ϫ1 cm Ϫ1 was independently determined for HBD3 by methods described earlier (25) . Static and dynamic light-scattering measurements were conducted with a DynaPro molecular sizing instrument (Protein Solution Inc.) operating at a wavelength of 822.4 nm. In the static light-scattering experiments, molecular masses were determined using the Debye analysis (31) . Calculated molecular masses were determined based on the sequences of the peptides. The change in the refractive index of protein solutions as a function of protein concentration (increment of refractive index, dn/dc) was assumed to be similar to that of most peptides. The dn/dc value of 0.20 ml/g was taken for molecular mass analysis. To estimate the hydrodynamic radii of the proteins in solution, dynamic light-scattering studies were also performed. The correlation functions of the scattered light intensity were analyzed using the regularization algorithm utilizing an inverse Laplace transformation (32) . All light-scattering studies were carried out at 20°C and at a 90°scattering angle.
NMR Spectroscopy-The NMR samples for HBD1 and HBD3 were made by dissolving ϳ1-2 mg of purified protein in 540 l of H 2 O and 60 l of D 2 O. The unbuffered pH was adjusted to 4.5 and 4.0 for HBD1 and HBD3, respectively. The concentration of each of the samples was determined by UV absorption in aqueous solution at 280 nm and calculated molar extinction coefficients of 4200 and 2920 M Ϫ1 cm Ϫ1 for HBD1 and HBD3, respectively.
To determine the optimal NMR conditions for each of the proteins, two-dimensional NOESY (mixing times of 400 and 150 ms for HBD1 and HBD3, respectively) and TOCSY (mixing times of 120 ms) spectra were acquired at 25, 30, and 37°C on a Bruker Avance 500-MHz NMR spectrometer equipped with a Cryo-probe TM . The spectra collected at 25°C were determined to provide the optimal resolution of overlapping NMR signals for both HBD1 and HBD3; therefore, this temperature was used for further studies of the proteins. For HBD3 and HBD1, a series of NOESY spectra were collected with mixing times between 50 -500 and 100 -800 ms, respectively, to determine the point at which spin-diffusion occurred. All spectra were acquired with 2048 ϫ 600 data points in the F2 and F1 dimensions, and sweep widths of 6009 Hz. In all NOESY and TOCSY spectra water suppression was achieved using excitation sculpting (33) . A DQF-COSY spectrum with 4096 ϫ 512 data points was also acquired to aid in the assignment of different spin systems. To determine the J-coupling constants of these proteins twodimensional DQF-COSY spectra of both HBD1 and HBD3 were acquired on a Varian 800-MHz NMR spectrometer at NANUC, the National High Field Nuclear Magnetic Resonance Center (University of Alberta, Edmonton, Alberta). Spectra at 800 MHz were acquired at 25°C with 8192 ϫ 2048 data points and sweep widths of 10000 ϫ 9000 Hz for the respective F2 and F1 dimensions. The water signal was suppressed using a 3-9-19 watergate pulse sequence with gradients and presaturation during the relaxation delay. J-couplings were measured from the 800-MHz DQF-COSY spectra by extracting one-dimensional slices through each of the HN-H␣ multiplet peaks and measuring the couplings directly using XWINNMR (Bruker, Analytische Messtechnik GmbH). All spectra were zero-filled and multiplied by a shifted sine-bell curve using the NMRPipe software package (34) .
To determine which amides were in slow exchange, the HBD1 and HBD3 NMR samples were lyophilized from H 2 O and re-dissolved in 99.9% D 2 O. Immediately after this, one-dimensional 1 H spectrum was acquired followed by a series of one-and two-dimensional 1 H spectra over the following 24 h.
For the NMR diffusion experiments, the HBD1 and HBD3 NMR samples in D 2 O were used. Additionally, an NMR sample for HBD2 was also prepared by dissolving ϳ2 mg of protein in 99.9% D 2 O with the pH adjusted to 4.5. The concentration was determined using UV absorption in aqueous solution at 280 nm, with a calculated molar extinction coefficient of 1640 M Ϫ1 cm Ϫ1 . Approximately 5 l of a 1% solution of dioxane in D 2 O was added to each of the samples as an internal standard. Pulsed field gradient diffusion experiments were collected with the PG-SLED sequence (35, 36) . The data was acquired by collecting 56 scans at each step and incrementing the gradient strength in 64 steps from 1.25 to 80% of the maximum gradient output of the linear amplifier. Data were initially processed using an inverse Laplace transform in the diffusion software addition to the Bruker XWINNMR package (version 2.6). From the resulting diffusion spectrum, not less then 10 protein resonances were chosen, and the decay of the peak intensities as a function of gradient strength was evaluated using the XWIN-NMR package.
Structure Calculation-NMR spectra were analyzed using NMRView 4.1.3 (37) on PC workstations running the Redhat 7.1 version of the Linux operating system. All NMR spectra were initially referenced to H 2 O at 4.77 ppm and subsequently referenced to dioxane at 3.751 ppm (separately referenced to 2,2-dimethyl-2-silapentane-5-sulfonic acid (DSS)). The assignment of the protein chemical shifts was determined using the method of Wü thrich (38) . NOE-based distance restraints were collected from NOESY spectra and separated into three groups, strong (1.8 -2.8 Å), medium (1.8 -3.4 Å), and weak (1.8 -5.0 Å), based on peak intensity by estimating the populations of each of these groups using the guess bins routine in NMRView 4.1.3. Where necessary, a pseudo-atom correction was added to the distance restraints for degenerate and non-stereospecifically assigned protons (38) . The dihedral angles were constrained by the addition of Karplus coupling constant constraints when the coupling constants measured from the DQF-COSY spectra measured at 800 MHz exceeded 8 Hz. Additionally, for the non-Gly and -Pro residues of HBD3, where a coupling constant could not reliably be determined, a broad dihedral angle restraint was used to restrain the -dihedral angle between Ϫ35°and Ϫ180°. The NOE distance restraints and dihedral angle restraints were then used to create initial protein structures starting from extended structures using the program CNS (version 1.0) (39) . Additionally, the 6 Cys residues were constrained to form three disulfide bonds based on the known disulfide pairing pattern of the ␤-defensins (13, 40) . CNS uses both a simulated annealing protocol and molecular dynamics to produce low energy structures with the minimum distance and geometry restraint violations. In general, the default parameters supplied with the program were used with 100 structures generated for each CNS run. The protein structures were further refined using the program ARIA (41-44) on an SGI R12000 work station. ARIA enables the incorporation of ambiguous NOE distance restraints into the structure calculations as well as calibrating the NOE distance restraints using a structure-based NOE back-calculation. ARIA runs were performed using the default parameters supplied in the program. In the final ARIA run the number of structures generated in the eighth iteration was increased to 100, and 20 structures were kept based on lowest energy.
RESULTS
Native Gel Electrophoresis-The effect of reducing the disulfide bonds of the three human ␤-defensins on their relative mobilities in a Tricine-acrylamide gel is shown in Fig. 1 . Before reduction of the disulfide bonds, HBD1 and HBD2 migrate on the gel with similar mobilities, whereas HBD3 ran significantly slower. It can be deduced by comparison to molecular weight standards that when the disulfide bonds are intact, HBD3 migrates as a dimer, whereas HBD1 and HBD2 migrate as monomers. After reduction of the disulfide bonds with dithiothreitol, the mobility of all three ␤-defensins increased, with their relative mobilities becoming more similar. We take this to indicate that cleavage of the disulfide bonds results in a disruption of the tertiary structure of HBD3 and the subsequent loss of a stable dimer structure.
Light Scattering-The physical state of HBD2 and HBD3 in solution was studied using dynamic and static light-scattering methods. Studies were performed on solutions ranging in protein concentration from 2.4 to 36.4 mg/ml. Proteins were first characterized with static light scattering as an absolute method for molecular mass analysis ( Fig. 2A) . Molecular masses of HBD2 and HBD3 were determined at infinite dilution as 4300 Ϯ 400 and 9600 Ϯ 800 Da, respectively. These values were then compared with values estimated from dynamic light scattering.
All size distributions obtained in dynamic light-scattering experiments were narrow and unimodal, indicating an absence of large intermolecular aggregates. The mean peak value of the hydrodynamic radius distributions was taken as an apparent hydrodynamic radius of scattering particles (R h , app ). For each of the solutions studied, measured values of R h,app in nm were converted into apparent molecular masses (M r,app ) using the relationship known for globular proteins (45) (see also Protein Solutions Inc. at www.protein-solutions.com),
The M r,app estimated from dynamic light scattering is plotted as a function of protein concentration in Fig. 2B . In a dynamic light-scattering experiment, the diffusion coefficient of a scattering particle is measured rather than its actual size. Diffusion is influenced by hydrodynamic interactions between particles in solution, which often result in a decrease of the measured (apparent) diffusion coefficient with increasing concentration. The true value of the translation diffusion coefficient is only obtained at infinite dilution. Thus, molecular masses of HBD2 and HBD3 estimated with dynamic light scattering are 4900 Ϯ 400 and 8200 Ϯ 400 Da, respectively.
Dynamic and static light-scattering data suggest that HBD2 in 0.1 M Tris, pH 8.0, is monomeric; the experimentally observed and calculated (4328.2 Da) molecular masses of HBD2 are the same. However, the measured molecular masses of HBD3 are about 2 times the monomeric mass of 5154.99 Da. This finding indicates that HBD3 most likely exists as a dimer in solution under the conditions studied. It is interesting to note that the dynamic light-scattering estimate of the M r of HBD3 is low. This value is calculated assuming a globular structure of HBD3. If the structure is prolonged (ellipsoidal), one would expect Equation 1 to under-predict the M r since the R h of an asymmetric particle is smaller than the R h of a globular particle having the same molecular mass. Thus, it appears that HBD3 dimers have a somewhat prolonged structure or asymmetric geometry.
NMR Diffusion-The NMR diffusion experiments were completed by adapting the method of Jones et al. (46) with dioxane as an internal standard. NMR diffusion measurements have recently come to the fore as a method to study the diffusion rate and shapes of proteins in solution. The methodology has been applied to various studies of protein unfolding (47, 48) . In this case, the three defensins provided an excellent opportunity to compare the mobility behavior of each molecule in solution. For HBD1 and HBD3, the resonance for the internal dioxane standard overlapped with protein resonances. For these samples the average diffusion coefficient was determined from 10 resonances in the protein, and this value was used in the biexponential fit of the decay of the dioxane signal. In the case of HBD2, the dioxane resonance did not overlap with the protein peaks, and the diffusion coefficient was measured using a mono-exponential fit. The relationship used (46) was,
where R h is the effective hydrodynamic radius of the protein and the dioxane reference, and D ref and D protein were the measured diffusion coefficients. The effective hydrodynamic radius of dioxane was taken as 2.12 Å (49). Calculation of the theoretical hydrodynamic radius for each of the three defensins was based upon the empirical equation for folded proteins,
where N is the number of residues in the protein (49) . Values for the effective hydrodynamic radii shown in Table I indicate HBD1 and HBD2 were monomeric at the measured concentration, whereas HBD3 appeared to be in a dimeric form, confirming the results obtained by native gel electrophoresis and light scattering mentioned above.
Spectral Acquisition/Assignment-Because of the difficulty and expense in producing mammalian antimicrobial proteins, we were limited to very small quantities of HBD1 and HBD3, resulting in NMR samples with concentrations of 500 and 360 M for HBD1 and HBD3, respectively. Normally these concentrations would be at the detection limit for NMR, but using a Cryo-probe on a 500 MHz NMR spectrometer, spectra were obtained with a reasonable number of scans (24 scans/increment), resulting in excellent signal-to-noise.
The spectra acquired at 25°C demonstrated good chemical shift dispersion, with limited spectral overlap, enabling the assignment of most of the spin systems for both HBD1 and HBD3 from the total correlation spectroscopy and DQF-COSY spectra using standard techniques (38) . For HN-H␣ crosspeaks that were near the water signal (i.e. residues Asn-4, Cys-23, Glu-27, and Cys-33 of HBD3) the spectra obtained at 30 and 37°C aided in the assignment of the chemical shifts for the H␣ protons. The only residues in HBD3 that proved difficult to assign were the amides of residues 34 -37. The linewidths of these amides were significantly broadened, which was not unexpected since these residues were expected to be in a flexible loop by comparison to the structures of other ␤-defensins (24, 25) . The connectivity of the different spin systems was determined from the NOEs between H␣ (i) and HN (iϩ1) . ight-scattering25 of HBD3 and Pro-18 of HBD1 were both determined to be in the trans conformation based on distinctive NOEs. In the case of HBD1 the disulfide bonds could be independently detected by NOEs between the ␤-protons, whereas for HBD3, this was not possible due to spectral overlap of the ␤-protons.
Structure Calculations-The chemical shift index (CSI) (50) for both HBD1 and HBD3 (Fig. 3A and 4A ) indicated that the secondary structures of both defensins were likely composed of short helical or near helical regions, as in the case of HBD1, and three ␤-strands. Initial structures were generated in CNS from restraints based on the three disulfide bonds and unambiguous NOEs between the three ␤-strands. NOEs describing the short N-terminal helical regions and the ␤-sheets for HBD3 and HBD1 are represented in Figs. 3 and 4 , respectively. After this, distance constraints for the unambiguous intra-and interresidue NOEs were assigned from the NOESY spectrum in an iterative fashion based on the lowest energy structures from the previous CNS run. Once low energy structures, with a minimum number of violations, were calculated by CNS, the automated assignment program ARIA was used for the assignment of ambiguous NOEs and to calibrate the NOE distance restraints. Based on the NOE build-up experiments, spin diffusion appeared to occur at mixing times greater than 400 ms for both HBD3 and HBD1. In the ARIA calculations the NOESY spectra with mixing times of 300 and 400 ms were initially used for HBD3 and HBD1, respectively. In later stages of the ARIA calculations additional NOEs were added from NOESY spectra collected in D 2 O (mixing time of 250 ms). Additional data from a NOESY spectra collected in H 2 O (mixing time of 200 ms) was added to the calculations for HBD3 to ensure consistency of the data. Hydrogen bond restraints were added to the calculations based on the amides, which were observed to be slowly exchanging in the D 2 O exchange experiment. Hydrogen bond acceptors were assigned based on the previous structures calculated by CNS. Inter-strand hydrogen bonds were assigned when an amide proton and carbonyl oxygen were within 2.4 Å and the plane of the bond did not exceed 35°, as calculated by MOLMOL (51) in at least half of the structures.
No amide protons present in the short N-terminal helical regions of HBD1 or HBD3 were observed to be present in the D 2 O exchange experiments immediately after the addition of D 2 O; therefore, no hydrogen-bonds were used for these regions.
Solution NMR Structures of HBD3-
The final 20 lowest energy structures for HBD3, generated by ARIA, demonstrate a three-stranded anti-parallel ␤-sheet with a short helical segment packed against one face of the ␤-sheet (Figs. 5A and 8C ). This fold resembles those that have been reported for other ␤-defensins, including the x-ray crystal structures of HBD1 (27) and HBD2 (26) and the NMR solution structures of HBD2 (25) and BNDB-12 (24), although bovine neutrophil ␤-defensin 12 lacks a helical segment at its N terminus. The 20 lowest energy structures overlay with global r.m.s. distances of 0.616 Å for the backbone atoms of residues 6 -44 ( Fig. 5 ) and 1.337 Å for the heavy atoms of residues 6 -44 (see Table II for additional structure statistics).
The initial six N-terminal residues of HBD3 are disordered due to a lack of any unambiguous long range NOEs for this region. Whereas it is possible that due to the length and orientation of this segment it could form a fourth ␤-strand if it were to hydrogen bond to the second ␤-strand, no definitive NOEs could be observed between either the backbone or side chain protons of residues 2-6 and residues 27-31. Immediately after the disordered N terminus is a short helical segment composed of residues 10 -14. The packing of this helix against the ␤-sheet is primarily constrained by the disulfide bond between Cys-11 and Cys-40. Additionally, there are van der Waals contacts between Ile-30 and the phenyl ring of Tyr-10.
Strands ␤1, ␤2, and ␤3 of HBD3 are formed by residues 17-19, 27-31, and 39 -43. The amide protons of Arg-17 and Ala-19 in strand ␤1 form hydrogen bonds to the carbonyl oxygens of Cys-41 and Lys-39 of strand ␤3. After strand ␤1 is a well defined long coil (residues 21-25). The packing of the coil against the ␤-sheet is aided by the constraint imposed by the disulfide bond between Cys-23 and Cys-41 and van der Waals contacts with the methyl of Ala-19. A type I turn follows the coil, instigated by the trans-proline at position 25. This turn is stabilized by a hydrogen bond between the carbonyl of Leu-24 and the amide of Glu-27. Strand ␤2 follows this tight-turn, forming a ␤-hairpin with strand ␤3. The amides of Glu-28 and Ile-30 in strand ␤2 make hydrogen bond contacts with the carbonyl oxygens of Arg-42 and Cys-40 in strand ␤3, respectively. Additionally, the amides of Cys-40, Arg-42, and Lys-44 are hydrogen-bonded to the carbonyl groups of Gly-31, Glu-28, and Lys-26, respectively. As has been described in the tertiary structures of other defensins, including HBD1 and HBD2 (25) (26) (27) , a ␤-bulge (52) is present at Ile-30 and Gly-31 of strand ␤2. The ␤-bulge is shaped primarily by NOEs from Gly-31-HN to Cys-40-HN and Lys-39-H␣ as well as NOEs from Lys-31-H␣ to Lys-39-H␣ and Arg-38-HN (Fig. 3B) . Aside from the N and C termini, the turn connecting strands ␤2 and ␤3 is the most flexible region of the structure (Fig. 6 ), in part due to the flexibility of Gly-37.
An interesting observation in the NMR spectra of HBD3 was that the chemical shift of the ⑀-NH proton of Arg-17 (9.185 ppm) was shifted significantly downfield from the expected value (7.30 ppm (50)). We assume that such a shift is most likely due to an electrostatic interaction between the positively charged guanidinium group of Arg-17 and a negatively charged carboxylate group from one of the two glutamates (residues 27 and 28). It is very difficult to directly observe such an interaction by NMR since an optimum salt bridge between an Arg guanidinium and a Glu carboxylate would result in the observable guanidinium protons and the ␥ protons of Glu to be separated by a distance greater than 5 Å. In all of the 20 structures of HBD3 the side chain of Arg-17 is located on the face of the ␤-sheet opposite the helical segment. Of the two Glu residues, the side chain of Glu-27 is the only one that is consistently on the same side of the ␤-sheet as Arg-17. In the 20 structures, the ⑀-HN and -HN protons of the guanidinium group of Arg-17 come within 2.12 Å (average 3.38 Ϯ 1.10 Å) and 2.42 Å (average 5.53 Ϯ 1.19 Å), respectively, of the carboxylate oxygens of Glu-27, whereas the same protons come within 11.2 Å (average 12.74 Ϯ 0.74 Å) and 12.2 Å (average 15.22 Ϯ 1.08 Å), respectively, of the carboxylate oxygens of Glu-28. This suggests that Arg-17 is participating in an electrostatic interaction with the side chain of Glu-27 (Fig. 7) . The results mentioned above suggest that HBD3 forms a dimer at the concentrations used in the NMR structural studies. The x-ray crystal structure of HBD2 hints that the dimer interface for HBD3 could occur between strand ␤1 of the two monomers, forming an anti-parallel ␤-sheet (27) . Based on the CSI of this region (Fig. 3A) and the monomer NMR structures determined here (Figs. 5A and 8C) , the formation of an intermonomer ␤-sheet through strand ␤1 would likely be centered on Cys-18. Any extension of the dimer interface would occur by hydrogen bonds forming through one or both of Gly-16 and Val-20. Based on these assumptions the spectra were examined for the indication that distinctive NOEs (cross-peaks between HN18-H␣19, H␣19-H␣17, H␣17-HN20, and HN20-HN16) supporting the formation of an anti-parallel ␤-sheet between two monomers could be observed, but none were found. A similar analysis was done for the possibility that the interface could be through strand ␤2, as discussed by Zimmermann et al. (24) for bovine neutrophil ␤-defensin 12. No unambiguous evidence could be observed for ␤2 as the dimer interface with Glu-28, Gln-29, or Ile-30 being centered in the inter-monomer sheet, since the locations where cross-peaks that would describe this interaction were overlapped with either water or other resonances. Using homonuclear NMR techniques it would not be possible to observe the formation of the dimer ␤-sheet if the ␤-strands of the two monomers were oriented in a parallel manner, since it would be impossible to distinguish between intra-and inter-monomer NOEs. Additionally, such a dimer would position the hydrophobic face of each of the monomers on opposite sides, which would not support the model of an amphipathic structure being necessary for membrane disruption (6) .
Solution NMR Structures of HBD1-The 20 final lowest energy structures for HBD1 generated by ARIA demonstrate a three-stranded anti-parallel ␤-sheet (Fig. 5B and 8A ) similar to the recent crystallographic data (27) . However, inspection of the NMR data indicates several differences. The hydrophilic residues Asp-1-Cys-5 begin with a random coil leading to an ␣-helical turn for residues Val-6 -Ser-8. The typical correlations for an ␣-helix are clearly absent at the beginning of the sequence but begin to develop for Val-6 -Ser-8 (Fig. 4A) . There are no strong and well defined interactions from the initial portion of this protein to any other part of the structure other than ␤-␤ proton interactions from Cys-5 to Cys-34. There are other ambiguous and poorly defined interactions that could be attributed to regions adjacent to Cys-5 interacting with residues adjacent to Cys-34. After a bend originating at Gly-9 and Gly-10, the first ␤-sheet emerges. The three ␤Ϫstrands are defined by the ␤1 strand from residues Gln-11-Leu-13, the ␤2 strand from residues Ile-23-Thr-26, and the ␤3 strand from Lys-33-Cys-35. Schematically the interactions, as verified in the two-dimensional NOESY and CSI, are indicated in Fig. 4B . Intermediate to the ␤1 and ␤2 strand two bends occur with the second developing a type IV turn immediately after the transPro-18. The characteristic ␤-defensin ␤-bulge is also present at Ile-23 and Gln-24. Between the ␤2 and ␤3 strands a well constrained (Fig. 6B ) type I turn is present from Tyr-28 to Lys-31. The r.m.s. distance for the heavy atoms of the lowest energy structures is 1.329 Å (Table II) and reduces to 0.451 Å for the backbone of residues His-2-Lys-33 (Fig. 5B) .
As with all ␤-defensins, the inter-strand cysteine disulfide bonds provide the initial structure, allowing hydrogen bonds to form between strands. For HBD1, the D 2 O exchange spectra indicate the presence of hydrogen-bonding interactions from backbone amide protons and backbone carbonyl oxygens between residues 11-35, 13-33, 24 -34, 34 -25, and 35-12. Between the three ␤-strands, there are the usual interactions characteristic of the sheet structure (Fig. 4B ). There are also other interesting features such as aromatic interactions between the two phenyl rings of Tyr-14 and Tyr-28 that give added stability to the overall structure.
Comparison of the NMR Structures of the Human ␤-Defensins-As mentioned above, the secondary structures of both HBD3 and HBD1 are similar to the NMR solution structure of HBD2 (25) (Fig. 8) . The C␣ backbone of HBD3 and HBD1 can be overlaid with an r.m.s. distance of 2.43 Å, whereas the C␣ r.m.s. distances of HBD3 and HBD1 with the NMR structure of HBD2 are 2.10 and 2.28 Å, respectively. The structural similarity is especially interesting due to the relatively low sequence identity between the human ␤-defensins (HBD3 has 31 and 29% identity between HBD1 and HBD2, respectively, whereas HBD2 has 42% identity to HBD1). This identity is primarily due to the conservation of structural residues responsible for the formation of the defensin-fold, the 6 Cys residues, Gly-1, 4 Gly-15/16, Gly-31, and Pro-25 (Fig. 9) . The increased basicity of HBD3 compared with HBD1 and HBD2 is clearly demonstrated in electrostatic surface plots of the three NMR structures of the human ␤-defensins (Fig. 10) . The positive charges are localized to one major face on all three of the defensins (top half of Fig. 10 ). The positive charges of HBD3 are asymmetrically positioned on the two sides of the surface, whereas in the other two ␤-defensins, the positive charges are localized to a distinct side of the surface. The potential salt bridge between Arg-17 and Glu-27 mentioned above, is clearly visible in Fig. 10 (bottom right panel) , with the positive charge of the guanidinium group shielding the negative charge of Glu-27.
DISCUSSION
Each of the human ␤-defensins appears to fill a specific biological niche in the innate immune system. HBD1 is constitutively expressed with specificity for Gram-negative bacteria, whereas the expression of HBD2 and HBD3 is constitutive and inducible, exhibiting broad microbicidal activity, 4 Sequence numbers are relative to HBD3. with HBD3 having the additional quality of anti-S. aureus activity at physiological salt concentrations. From our results it is clear that the human ␤-defensin family of antimicrobial peptides retain their cysteine consensus sequence and tertiary structure, whereas they have microbicidal activity that is optimized for specific organisms. A comparison of the NMR structures of the three related human ␤-defensins should aid in an understanding of the antimicrobial specificity of these proteins.
Of the three human ␤-defensins, HBD3 has approximately twice the net positive charge density (ϩ11) compared with HBD1 (ϩ4) and HBD2 (ϩ6) (Fig. 9) . The charge density is asymmetrically distributed on the molecular surface of all three defensins, although as expected the positively charged surface of HBD3 includes a larger percentage of the total surface area, encircling the structure (Fig. 10) . The increase in the net positive charge is partly responsible for the low sequence similarity between HBD3 and HBD1 and HBD2. There is a large insertion of Arg and Lys residues at the C terminus of HBD3. The conserved Thr preceding the fourth Cys is replaced by a Lys residue; in addition, other cationic residues are inserted at positions 8, 12, 14, and 17. Resistance to cationic antimicrobial peptides by S. aureus has been linked to the capping of the negatively charged phosphate groups of teichoic acid by Ala or Lys, decreasing the net negative charge on the cell surface (53, 54) . The increased positive charge of HBD3 compared with HBD1 and HBD2 may compensate for the decreased acidity of the surface of S. aureus compared with the surfaces of Gram-negative bacteria such as E. coli and P. aeruginosa.
It has been demonstrated that both ␣-and ␤-defensins will cause disruption of cellular membranes (5) (6) (7) 55) . Additionally, there is significant evidence that many ␣-defensins can induce leakage in vesicles in a charge-dependent manner, with permeabilization significantly decreasing as the ratio of anionic lipids is decreased (6, 56 -60). To our knowledge, the only study that has examined vesicle leakage for ␤-defensins was performed with HBD2, and as was observed for the ␣-defensins, the extent of leakage was charge-dependent (26) . Recently HBD3 has been shown to form ion channels in the membranes of X. laevis oocytes (23) . It is interesting to note that without the correct bonding of the Cys residues in HBD2 to form the disulfide bonds, likely resulting in misfolding of the tertiary structure (Fig. 1) , the ability to disrupt vesicles is dramatically decreased (26) . The disruption of bacterial membranes by ␣-defensins has been proposed to occur by either pore formation, as in the case of the dimeric ␣-defensin, human neutrophil protein HNP-2, or by graded leakage of vesicles as was described for the monomeric rabbit defensins (59, 60) .
A relationship between the affinity of the ␣-defensins to form dimers in solution and an increased ability to form multimeric pores in vesicles has been previously reported (59) . Although the mechanism of membrane disruption has yet to be confirmed for the human ␤-defensins, it is likely that the increased capacity of HBD3 to form dimers in solution compared with HBD1 and HBD2 contributes to the enhanced potency of HBD3. The NMR data used for the assignment and structural determination of HBD3 indicate that dimer formation would likely only occur in a symmetrical manner. If this were not the case, some of the residues in each of the monomers participating in the dimer interface would experience different chemical environments and would have different chemical shifts. This brings about a problem for homonuclear NMR spectroscopy, since it is difficult to observe dimer specific NOEs (e.g. see also Ref. 30) . This is further complicated in the case of a putative defensin dimer, since the dimer interface would be expected to occur between two short ␤-strands (each strand consisting of 2-4 residues) to form a 6-stranded ␤-sheet, as has been observed in the crystal structure of HBD2 (26) .
Based on the NMR data, a dimer interface at strand ␤1 for HBD3 is unlikely since the distinctive NOEs that would be present were not observed. On the other hand a dimer interface centered on strand ␤2 cannot be ruled out based on the NOE evidence, as mentioned above. In addition, a dimer interface at strand ␤2 positions the side chains of Glu-28 and Lys-32 to make two stabilizing inter-monomer electrostatic interactions with each other. The side chain of Gln-29 would also be oriented to allow hydrogen bonds to form with the matching Gln-29 of the second monomer (Fig. 11) . The potential importance of Gln-29 is stressed by the conservation of this residue through most of the ␤-defensins (2), whereas the increased affinity of HBD3 to form dimers could be explained by the presence of the two Glu residues in the ␤2 strand, since these residues are not present in any other known ␤-defensin. Zimmermann et al. (24) suggest that the conserved Thr preceding the fourth Cys may play a role in dimer formation, yet HBD3 is the only ␤-defensin that lacks this residue (2, 7) while retaining its ability to form dimers in solution. It is possible that the high net positive charge of HBD3 could inhibit dimer formation by electrostatic repulsion, yet the potential saltbridges between Lys-32 and Glu-28 remove the majority of the charge surrounding strand ␤2.
In all three of the surface plots of the ␤-defensins (Fig. 10) , amphipathic structures are formed, with the cationic residues on one surface and hydrophobic patches on the opposing surface. The hydrophobic residues on HBD1 and HBD3 are clustered at the bottom of the surfaces in the figure, including residues Phe-20, Tyr-14, Ile-119, and Leu-13 of HBD1 and Leu-21, Leu-24, Val-20, and Pro-25 of HBD3. The hydrophobic residues form a significantly larger surface on HBD2, including residues Phe-19, Val-18, Tyr-24, Pro-17, Leu-22, Pro-33, and Ile-14. This surface can be clearly observed in the bottom middle panel of Fig. 10 . If HBD3 were to form a dimer across strand ␤2, as discussed above, the hydrophobic patch of each monomer would be positioned together to form a larger hydrophobic surface, similar to that of HBD2.
It is difficult to determine which other residues of HBD3 cause the increase in the anti-S. aureus activity due to the low sequence similarity among the ␤-defensins. Even for other ␤-defensins such as tracheal antimicrobial protein (12) , which also have significant anti-S. aureus activity, there is very little sequence conservation between HBD3 and tracheal antimicrobial protein other than the structural residues (Cys, Gly, and Pro) and a high net positive charge (Fig. 9) .
This study demonstrates that there are only minor differences in the tertiary structures of the three human ␤-defensins. We therefore propose that it is the higher net positive charge and the increased affinity to form dimers in solution that lead to the improved anti-S. aureus microbicidal activity of HBD3 and retention of killing at physiologic salt concentrations. Although it is evident that HBD3 forms dimers at low concentrations, the location of the dimer interface remains to be confirmed, possibly by heteronuclear NMR studies. Studies where Glu-28, Gln-29, and Lys-32 are mutated must be performed to determine whether they have an effect on the dimerization of HBD3, and consequently, if this alters the antimicrobial activity of this peptide. FIG. 9 . Sequence homology of HBD1-3 and bovine tracheal antimicrobial protein (TAP). Homologous residues among the defensins are highlighted. It should be noted that whereas the 42-residue sequence of HBD1 has been used for the alignment, the alignment does not alter for the 36-residue fragment used in this study. In addition to the sequence homology between the ␤-defensins, the net positive charge is also indicated. a , the net positive charge for both the 42-residue and the 36-residue HBD1 peptides is indicated. Alignment was performed with the ClustalX program (61).
FIG. 10.
Electrostatic surface plots of the most representative NMR structures of the three human ␤-defensins. HBD1, HBD2, and HBD3 are diagramed from left to right in the figure. In the top half of the figure the C terminus of each of the structures is positioned on the right, and the N-terminal helix is at the top, whereas in the bottom half of the figure the structures are rotated 180°, and the C termini are now on the left, whereas the N-terminal helical regions remain at the top. The basic regions of the protein are colored blue, whereas the red regions are acidic. This figure was generated with GRASP (62) .   FIG. 11 . Possible orientations of two HBD3 monomers to form a dimer. Intermonomer hydrogen bonds between strand ␤2 of each of the monomers would establish a 6-stranded ␤-sheet. The dimer interface could be stabilized by the electrostatic interaction of Lys-32 and Glu-28 in addition to inter-monomer hydrogen bonds between the side chains of Gln-29. It should be noted that the positioning of the two monomers is only a model to illustrate the potential interactions if strand ␤2 were the dimer interface. Atoms of the two monomers may be overlapping, and correct bond distances have not been accounted for. This figure was created using the program MOLMOL (51) .
